AMRA Medical will present “Two years of aging – initial results on changes in muscle composition in the UK Biobank imaging study”…
Medical Research
AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study
Eli Lilly and Company assessed the impact of tirzepatide, an investigational therapy for the treatment of type 2 diabetes, on liver fat,…
AMRA Webinar: The Patient Experience Using MRI in DMD Clinical Trials – “Shed Light Through MRI”
Join us – with patients, industry leaders and a patient advocacy group to learn how to implement a magnetic resonance imaging (MRI)…
AMRA Medical, Daiichi Sankyo and NCNP joint MRI-based muscle research accepted for poster presentation at 2022 MDA Conference
LINKÖPING, Sweden; March 14, 2022—AMRA’s recent research, performed in collaboration with Daiichi Sankyo and the National Center of Neurology and Psychiatry (NCNP)…
AMRA Medical’s MRI data provide a unique opportunity for Pfizer’s GWAS
LINKÖPING, Sweden; February 14, 2022—One of the goals of AMRA’s collaboration with Pfizer and UK Biobank is to help identify and validate…
AMRA Medical Introduces Paradigm-shifting MRI Analysis Services at RSNA 2021
LINKÖPING, Sweden; November 24, 2021 – AMRA Medical will introduce two high-precision magnetic resonance imaging (MRI) analysis services for assessing body composition…